Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers

AGORACOM News Flash

If you're not following the AGORACOM Blog, you are missing great and informative market posts such as my weekly small-cap market talk with Peter Grandich.

Listen to this week's show that discusses the significance of this week's events on small-cap markets, including sovereign debt, the $USD Index and falling gold prices.

Message: Biocurex Cash Position

080115_sheen
Rank: [?]
Treasurer
Points: [?]
835
Rating: [?]
Votes: 11 Score: 2.7
  • Currently 2.7/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Biocurex Cash Position

posted on Dec 09, 08 02:54PM
Has Biocurex secured enough cash to continue operating
beyond December 2008?


From the latest Form-10-Q:

"As of November 14, 2008 Biocurex has cash on hand
 of approximately $90,000. Biocurex is presently spending
 approximately $200,000 each month on research and
 development, principal and interest payments to the
Note Holders, and general and administrative expenses.

5
<PAGE>

To maintain its present level of operations, including
 research and development, and to avoid defaulting on
payments to the Note Holders, Biocurex will need to raise
 approximately $4,000,000 to satisfy its monthly cash
requirements until the notes are fully paid."


New Message

Please login to post a reply

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote